Arthur S. Przybyl
Overview
Arthur S. Przybyl received an average of $3M in total compensation, including $536K in salary, at ANI Pharmaceuticals from 2013 to 2020.
2020ANI PharmaceuticalsFormer President and Chief Executive Officer
2019ANI PharmaceuticalsPresident, Chief Executive Officer and Director
2018ANI PharmaceuticalsPresident, Chief Executive Officer and Director
2017ANI PharmaceuticalsPresident, Chief Executive Officer and Director
2016ANI PharmaceuticalsPresident, Chief Executive Officer and Director
2015ANI PharmaceuticalsPresident, Chief Executive Officer and Director
2014ANI PharmaceuticalsPresident, Chief Executive Officer and Director
2013ANI PharmaceuticalsPresident, Chief Executive Officer and Director
Source: SEC filings on April 29, 2021, April 23, 2020, April 4, 2019, April 6, 2018, April 6, 2017, and April 14, 2016.
Related executives
We found 11 more executives who work or worked at ANI Pharmaceuticals.
Nikhil Lalwani
ANI Pharmaceuticals
Chief Executive Officer
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
Christopher Mutz
ANI Pharmaceuticals
Head of Rare Disease
Ori Gutwerg
ANI Pharmaceuticals
Senior Vice President, Generics
Robert Schrepfer
ANI Pharmaceuticals
Former Senior Vice President, New Business Development and Specialty Sales
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
Charlotte Arnold
ANI Pharmaceuticals